These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38029042)

  • 1. Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options - Review Article.
    Zimek D; Miklusova M; Mares J
    Neuropsychiatr Dis Treat; 2023; 19():2485-2497. PubMed ID: 38029042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT; Wang L; Deng XY; Yu G
    J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usability of a Mobile App for Real-Time Assessment of Fatigue and Related Symptoms in Patients With Multiple Sclerosis: Observational Study.
    Palotai M; Wallack M; Kujbus G; Dalnoki A; Guttmann C
    JMIR Mhealth Uhealth; 2021 Apr; 9(4):e19564. PubMed ID: 33861208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in multiple sclerosis - a brief review.
    Induruwa I; Constantinescu CS; Gran B
    J Neurol Sci; 2012 Dec; 323(1-2):9-15. PubMed ID: 22935407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of fatigue in patients with multiple sclerosis.
    Zifko UA
    Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of amantadine for the treatment of fatigue in multiple sclerosis: a systematic review and meta-analysis.
    Perez DQ; Espiritu AI; Jamora RDG
    Neurodegener Dis Manag; 2020 Dec; 10(6):383-395. PubMed ID: 33012266
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatigue and multiple sclerosis.
    Béthoux F
    Ann Readapt Med Phys; 2006 Jul; 49(6):265-71, 355-60. PubMed ID: 16757056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue.
    Veauthier C; Hasselmann H; Gold SM; Paul F
    EPMA J; 2016; 7(1):25. PubMed ID: 27904656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment, pathophysiology and treatment of fatigue in multiple sclerosis.
    Comi G; Leocani L
    Expert Rev Neurother; 2002 Nov; 2(6):867-76. PubMed ID: 19810920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on the diagnosis and management of fatigue in multiple sclerosis.
    Marchesi O; Vizzino C; Filippi M; Rocca MA
    Expert Rev Neurother; 2022 Aug; 22(8):681-693. PubMed ID: 35881416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential pathophysiological pathways that can explain the positive effects of exercise on fatigue in multiple sclerosis: A scoping review.
    Langeskov-Christensen M; Bisson EJ; Finlayson ML; Dalgas U
    J Neurol Sci; 2017 Feb; 373():307-320. PubMed ID: 28131211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology and treatment of fatigue in multiple sclerosis].
    Boërio D; Lefaucheur JP; Hogrel JY; Créange A
    Rev Neurol (Paris); 2006 Mar; 162(3):311-20. PubMed ID: 16585886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine treatment of fatigue associated with multiple sclerosis.
    Cohen RA; Fisher M
    Arch Neurol; 1989 Jun; 46(6):676-80. PubMed ID: 2730380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in multiple sclerosis - Insights into evaluation and management.
    Ayache SS; Chalah MA
    Neurophysiol Clin; 2017 Apr; 47(2):139-171. PubMed ID: 28416274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue associated with multiple sclerosis: diagnosis, impact and management.
    Bakshi R
    Mult Scler; 2003 Jun; 9(3):219-27. PubMed ID: 12814166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.
    Braley TJ; Chervin RD
    Sleep; 2010 Aug; 33(8):1061-7. PubMed ID: 20815187
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.